6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline

C160H231BrF3N19O8 — CID 158713395

IUPAC6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline
SMILESCC(C)(C)C(=O)N1CCC(Oc2ccc(C(C)(C)C)cc2)CC1.CC(C)(C)c1ccc(OC2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc2cc(O)ccc2c1.CC(C)(C)c1ccnc(CCCNCC(F)(F)F)c1.CC(C)(C)c1ccnc(Cc2cc(C(C)(C)C)n[nH]2)c1.CC(C)(C)c1ccnc(NCCN)c1.CC(C)(C)c1ccnc(OC2CCOCC2)c1.CC(C)(C)c1cnc2ccccc2c1.CC(C)(C)c1nc2ccc(Br)cc2[nH]1.CN(c1cc(C(C)(C)C)ccn1)C1CCOCC1.Cn1nccc1Cc1cc(C(C)(C)C)ccn1
InChIInChI=1S/C20H31NO2.C17H25N3.C17H27NO2.C15H24N2O.C14H21F3N2.C14H19N3.C14H21NO2.C14H16O.C13H15N.C11H13BrN2.C11H19N3/c1-19(2,3)15-7-9-16(10-8-15)23-17-11-13-21(14-12-17)18(22)20(4,5)6;1-16(2,3)12-7-8-18-13(9-12)10-14-11-15(20-19-14)17(4,5)6;1-17(2,3)14-4-6-15(7-5-14)20-16-8-10-18(11-9-16)12-13-19;1-15(2,3)12-5-8-16-14(11-12)17(4)13-6-9-18-10-7-13;1-13(2,3)11-6-8-19-12(9-11)5-4-7-18-10-14(15,16)17;1-14(2,3)11-5-7-15-12(9-11)10-13-6-8-16-17(13)4;1-14(2,3)11-4-7-15-13(10-11)17-12-5-8-16-9-6-12;1-14(2,3)12-6-4-11-9-13(15)7-5-10(11)8-12;1-13(2,3)11-8-10-6-4-5-7-12(10)14-9-11;1-11(2,3)10-13-8-5-4-7(12)6-9(8)14-10;1-11(2,3)9-4-6-13-10(8-9)14-7-5-12/h7-10,17H,11-14H2,1-6H3;7-9,11H,10H2,1-6H3,(H,19,20);4-7,16,19H,8-13H2,1-3H3;5,8,11,13H,6-7,9-10H2,1-4H3;6,8-9,18H,4-5,7,10H2,1-3H3;5-9H,10H2,1-4H3;4,7,10,12H,5-6,8-9H2,1-3H3;4-9,15H,1-3H3;4-9H,1-3H3;4-6H,1-3H3,(H,13,14);4,6,8H,5,7,12H2,1-3H3,(H,13,14)
InChIKeyIIZVSRJPSRUSGQ-UHFFFAOYSA-N
MW2685.63 g/mol
LogP36.06
Rot. Bonds22

About 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline

6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline (PubChem CID 158713395) has the molecular formula C160H231BrF3N19O8 and a molecular weight of 2685.63 g/mol. Its IUPAC name is 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline.

Molecular Properties

Compound Name6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline
PubChem CID158713395
Molecular FormulaC160H231BrF3N19O8
Molecular Weight2685.63 g/mol
Exact Mass2682.74
IUPAC Name6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline
SMILESCC(C)(C)C(=O)N1CCC(Oc2ccc(C(C)(C)C)cc2)CC1.CC(C)(C)c1ccc(OC2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc2cc(O)ccc2c1.CC(C)(C)c1ccnc(CCCNCC(F)(F)F)c1.CC(C)(C)c1ccnc(Cc2cc(C(C)(C)C)n[nH]2)c1.CC(C)(C)c1ccnc(NCCN)c1.CC(C)(C)c1ccnc(OC2CCOCC2)c1.CC(C)(C)c1cnc2ccccc2c1.CC(C)(C)c1nc2ccc(Br)cc2[nH]1.CN(c1cc(C(C)(C)C)ccn1)C1CCOCC1.Cn1nccc1Cc1cc(C(C)(C)C)ccn1
InChIInChI=1S/C20H31NO2.C17H25N3.C17H27NO2.C15H24N2O.C14H21F3N2.C14H19N3.C14H21NO2.C14H16O.C13H15N.C11H13BrN2.C11H19N3/c1-19(2,3)15-7-9-16(10-8-15)23-17-11-13-21(14-12-17)18(22)20(4,5)6;1-16(2,3)12-7-8-18-13(9-12)10-14-11-15(20-19-14)17(4,5)6;1-17(2,3)14-4-6-15(7-5-14)20-16-8-10-18(11-9-16)12-13-19;1-15(2,3)12-5-8-16-14(11-12)17(4)13-6-9-18-10-7-13;1-13(2,3)11-6-8-19-12(9-11)5-4-7-18-10-14(15,16)17;1-14(2,3)11-5-7-15-12(9-11)10-13-6-8-16-17(13)4;1-14(2,3)11-4-7-15-13(10-11)17-12-5-8-16-9-6-12;1-14(2,3)12-6-4-11-9-13(15)7-5-10(11)8-12;1-13(2,3)11-8-10-6-4-5-7-12(10)14-9-11;1-11(2,3)10-13-8-5-4-7(12)6-9(8)14-10;1-11(2,3)9-4-6-13-10(8-9)14-7-5-12/h7-10,17H,11-14H2,1-6H3;7-9,11H,10H2,1-6H3,(H,19,20);4-7,16,19H,8-13H2,1-3H3;5,8,11,13H,6-7,9-10H2,1-4H3;6,8-9,18H,4-5,7,10H2,1-3H3;5-9H,10H2,1-4H3;4,7,10,12H,5-6,8-9H2,1-3H3;4-9,15H,1-3H3;4-9H,1-3H3;4-6H,1-3H3,(H,13,14);4,6,8H,5,7,12H2,1-3H3,(H,13,14)
InChIKeyIIZVSRJPSRUSGQ-UHFFFAOYSA-N
XLogP36.06
TPSA328.89 Ų
H-Bond Donors7
H-Bond Acceptors24
Rotatable Bonds22
Heavy Atoms191
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002685.63
LogP ≤ 536.06
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline?
The IUPAC name of 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline (CID 158713395) is 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline.
What is the SMILES notation for 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline?
The canonical SMILES for 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline is CC(C)(C)C(=O)N1CCC(Oc2ccc(C(C)(C)C)cc2)CC1.CC(C)(C)c1ccc(OC2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc2cc(O)ccc2c1.CC(C)(C)c1ccnc(CCCNCC(F)(F)F)c1.CC(C)(C)c1ccnc(Cc2cc(C(C)(C)C)n[nH]2)c1.CC(C)(C)c1ccnc(NCCN)c1.CC(C)(C)c1ccnc(OC2CCOCC2)c1.CC(C)(C)c1cnc2ccccc2c1.CC(C)(C)c1nc2ccc(Br)cc2[nH]1.CN(c1cc(C(C)(C)C)ccn1)C1CCOCC1.Cn1nccc1Cc1cc(C(C)(C)C)ccn1.
What is the InChIKey of 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline?
The InChIKey is IIZVSRJPSRUSGQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H31NO2.C17H25N3.C17H27NO2.C15H24N2O.C14H21F3N2.C14H19N3.C14H21NO2.C14H16O.C13H15N.C11H13BrN2.C11H19N3/c1-19(2,3)15-7-9-16(10-8-15)23-17-11-13-21(14-12-17)18(22)20(4,5)6;1-16(2,3)12-7-8-18-13(9-12)10-14-11-15(20-19-14)17(4,5)6;1-17(2,3)14-4-6-15(7-5-14)20-16-8-10-18(11-9-16)12-13-19;1-15(2,3)12-5-8-16-14(11-12)17(4)13-6-9-18-10-7-13;1-13(2,3)11-6-8-19-12(9-11)5-4-7-18-10-14(15,16)17;1-14(2,3)11-5-7-15-12(9-11)10-13-6-8-16-17(13)4;1-14(2,3)11-4-7-15-13(10-11)17-12-5-8-16-9-6-12;1-14(2,3)12-6-4-11-9-13(15)7-5-10(11)8-12;1-13(2,3)11-8-10-6-4-5-7-12(10)14-9-11;1-11(2,3)10-13-8-5-4-7(12)6-9(8)14-10;1-11(2,3)9-4-6-13-10(8-9)14-7-5-12/h7-10,17H,11-14H2,1-6H3;7-9,11H,10H2,1-6H3,(H,19,20);4-7,16,19H,8-13H2,1-3H3;5,8,11,13H,6-7,9-10H2,1-4H3;6,8-9,18H,4-5,7,10H2,1-3H3;5-9H,10H2,1-4H3;4,7,10,12H,5-6,8-9H2,1-3H3;4-9,15H,1-3H3;4-9H,1-3H3;4-6H,1-3H3,(H,13,14);4,6,8H,5,7,12H2,1-3H3,(H,13,14).
What are the key properties of 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline?
6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline has a molecular weight of 2685.63 g/mol, XLogP of 36.06, 22 rotatable bonds, 7 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-2-tert-butyl-1H-benzimidazole;4-tert-butyl-2-[(3-tert-butyl-1H-pyrazol-5-yl)methyl]pyridine;4-tert-butyl-N-methyl-N-(oxan-4-yl)pyridin-2-amine;4-tert-butyl-2-[(2-methylpyrazol-3-yl)methyl]pyridine;6-tert-butylnaphthalen-2-ol;4-tert-butyl-2-(oxan-4-yloxy)pyridine;1-[4-(4-tert-butylphenoxy)piperidin-1-yl]-2,2-dimethylpropan-1-one;2-[4-(4-tert-butylphenoxy)piperidin-1-yl]ethanol;N'-(4-tert-butyl-2-pyridinyl)ethane-1,2-diamine;3-(4-tert-butyl-2-pyridinyl)-N-(2,2,2-trifluoroethyl)propan-1-amine;3-tert-butylquinoline is sourced from PubChem (CID 158713395), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).